Form4.ai tracks every SEC insider trade in real time. See every ARQT insider filing with a free account — no card.
See every ARQT insider filing — free account, no card.
Free accountArcutis Biotherapeutics, Inc. (ARQT) has 10 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 6 sales totalling $851K. Most recent filing: Oct. 28, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 28, 2026 SEC filing | SCOTT ROBERT A Director | Grant / award | — | — |
| Oct 19, 2026 SEC filing | Welgus Howard G. Director | Sold | $17,074 | — |
| Sep 18, 2026 SEC filing | Matsuda Masaru See Remarks | Sold | $91,853 | — |
Create a free account to see all 10 ARQT filings from the last 90 days. No card needed.
Create free accountWant ARQT insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.